Home › The Angeles Clinic and Research Institute Releases Interim Data from...
 

Keywords :   


The Angeles Clinic and Research Institute Releases Interim Data from...

2013-06-05 09:48:23| Logistics - Topix.net

The Angeles Clinic and Research Institute has released preliminary results from an ongoing Phase IB expansion study evaluating the safety and efficacy of lambrolizumab , an investigational antibody therapy currently being developed by Merck that targets programmed cell death-1 protein in patients with advanced melanoma.

Tags: from data research angeles

Category:Transportation and Logistics

Latest from this category

All news
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
Transportation and Logistics »
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
26.06LG and Blacknut provide cloud video games through webOS
26.06Universal UK resort to open 365 days a year
26.06Steelwork closures' ripple effect on town's wages
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
More »